Darbepoetin Alfa Administered Every Three Weeks Is Effective for the Treatment of Chemotherapy-Induced Anemia
Ralph V. Boccia(Center for Cancer and Blood Disorders), Peter T. Silberstein(CHI Health Creighton University Medical Center - Bergan Mercy), Stephen P. Kahanic(June E. Nylen Cancer Center), Tom Lillie, Randall Liu(Straub Medical Center), Imtiaz A. Malik(Loma Linda University Medical Center), Dianne Tomita, Vinay Raja, Billy Clowney
Cited by 40
Related Papers
Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study
|Breast Cancer Research and Treatment|2017|761
Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy
|European Journal of Cancer|1993|545
Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia
|New England Journal of Medicine|2010|425